Home/Filings/4/0001179110-12-012300
4//SEC Filing

BOWEN R WILLIAM 4

Accession 0001179110-12-012300

CIK 0000820237other

Filed

Aug 1, 8:00 PM ET

Accepted

Aug 2, 4:42 PM ET

Size

25.1 KB

Accession

0001179110-12-012300

Insider Transaction Report

Form 4
Period: 2012-08-01
BOWEN R WILLIAM
Senior VP, General Counsel
Transactions
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2012-08-01$44.24/sh10,600$468,9440 total
    Exercise: $38.51Exp: 2016-08-17Common Stock (10,600 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2012-08-01$18.95/sh28,251$535,3560 total
    Exercise: $63.80Exp: 2018-02-10Common Stock (28,251 underlying)
  • Disposition to Issuer

    Common Stock

    2012-08-01$82.75/sh15,020$1,242,9050 total
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2012-08-01$40.25/sh3,265$131,4160 total
    Exercise: $42.50Exp: 2015-10-17Common Stock (3,265 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2012-08-01$21.93/sh23,000$504,3900 total
    Exercise: $60.82Exp: 2014-08-15Common Stock (23,000 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2012-08-0126,8920 total
    Exercise: $69.22Exp: 2019-02-10Common Stock (26,892 underlying)
  • Disposition to Issuer

    Performance Stock Rights

    2012-08-0111,0280 total
    Exercise: $0.00Exp: 2015-02-10Common Stock (11,028 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2012-08-01$22.60/sh15,000$339,0000 total
    Exercise: $60.15Exp: 2015-08-15Common Stock (15,000 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2012-08-01$40.09/sh30,300$1,214,7270 total
    Exercise: $42.66Exp: 2017-02-10Common Stock (30,300 underlying)
  • Disposition to Issuer

    Performance Stock Rights

    2012-08-013,2090 total
    Exercise: $0.00Exp: 2014-02-10Common Stock (3,209 underlying)
Footnotes (5)
  • [F1]This stock option was canceled pursuant to the Agreement and Plan of Merger, dated as of April 29, 2012, by and among the Registrant, Hologic, Inc. ("Hologic"), and Gold Acquisition Corp. (the "Merger Agreement"), in exchange for a payment in cash, without interest and less the amount of any required tax withholding, equal to the product of: (i) the excess of $82.75 (the per share merger consideration pursuant to the Merger Agreement) over the exercise price of the stock option; and (ii) the number of shares of common stock of the Registrant underlying the stock option.
  • [F2]25% of the shares subject to the stock option vest on February 10, 2013, and the remaining shares vest in equal monthly installments over the following three years.
  • [F3]Pursuant to the Merger Agreement, these options were assumed by Hologic and converted into options to acquire that number of shares of Hologic common stock which is equal to the number of shares of common stock of the Registrant subject to such options immediately prior to the merger multiplied by 4.51174963 with a per share exercise price equal to the quotient determined by dividing the per share exercise price of such options immediately prior to the merger by 4.51174963.
  • [F4]The performance stock rights were canceled pursuant to the Merger Agreement and converted into the right to receive a payment in cash, without interest and less the amount of any required tax withholding, equal to the product of: (i) $82.75 (the per share merger consideration pursuant to the Merger Agreement); and (ii) 4,813 (which amount equals 150% of the target number of shares of common stock of the Registrant underlying the performance stock rights).
  • [F5]The performance stock rights were canceled pursuant to the Merger Agreement and converted into the right to receive a payment in cash, without interest and less the amount of any required tax withholding, equal to the product of: (i) $82.75 (the per share merger consideration pursuant to the Merger Agreement); and (ii) 8,271 (which amount equals 150% of the target number of shares of common stock of the Registrant underlying the performance stock rights).

Issuer

GEN PROBE INC

CIK 0000820237

Entity typeother

Related Parties

1
  • filerCIK 0001230048

Filing Metadata

Form type
4
Filed
Aug 1, 8:00 PM ET
Accepted
Aug 2, 4:42 PM ET
Size
25.1 KB